Skip to main content
Year archive

M1 Kliniken AG — 2024 filings

All 20 regulatory filings released by M1 Kliniken AG (M12) in 2024, sourced directly from the official regulator.

20 Filings
2024 Period
2024 filings (20)
Filing Released Lang
M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
Earnings Release 9M 2024
2024-11-19 English
Half-yearly financial statements 2024
Interim / Quarterly Report H1 2024
2024-10-24 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Audit Report / Information FY 2022
2024-09-25 German
Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
Earnings Release H1 2024
2024-09-03 English
M1 Kliniken AG: Management Board confirms growth targets
Management Reports
2024-06-21 English
M1 Kliniken AG: Attila Strauss, sell
Director's Dealing
2024-06-20 English
Annual financial statements 2023
Annual Report FY 2023
2024-06-20 English
M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
Board/Management Information
2024-06-11 English
M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024
Earnings Release Q1 2024
2024-06-06 English
M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
Earnings Release FY 2023
2024-05-23 English
M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
Notice of Dividend Amount
2024-05-07 English
M1 Kliniken AG decides to start share buyback
Transaction in Own Shares
2024-04-26 English
M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to 316,3 million; EBIT increases by 68% to 15.7 million
Earnings Release FY 2023
2024-04-18 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Annual Report FY 2022
2024-02-20 German
M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024
M&A Activity
2024-02-16 English
Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting to the Prime Standard
Director's Dealing
2024-02-05 English
M1 Kliniken AG: Kilian Brenske, buy
Director's Dealing
2024-02-02 English
M1 Kliniken AG: Attila Strauss, buy
Director's Dealing
2024-02-02 English
M1 Kliniken AG: Attila Strauss, sell
Director's Dealing
2024-02-02 English
Invitation to the virtual AlsterResearch Healthcare Pop-Up Conference on 23 January 2024 at 1:30 pm
Report Publication Announcement
2024-01-22 English